Free Trial

R1 RCM (RCM) Competitors

$12.99
+0.11 (+0.85%)
(As of 05:27 PM ET)

RCM vs. TMX, MANT, PINC, FC, LH, DGX, DVA, CHE, CRVL, and AMED

Should you be buying R1 RCM stock or one of its competitors? The main competitors of R1 RCM include Terminix Global (TMX), ManTech International (MANT), Premier (PINC), Franklin Covey (FC), Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), CorVel (CRVL), and Amedisys (AMED).

R1 RCM vs.

R1 RCM (NASDAQ:RCM) and Terminix Global (NYSE:TMX) are both mid-cap business services companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, community ranking, analyst recommendations, profitability, dividends, valuation and earnings.

Terminix Global has lower revenue, but higher earnings than R1 RCM. R1 RCM is trading at a lower price-to-earnings ratio than Terminix Global, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
R1 RCM$2.25B2.43$3.30M-$0.08-162.38
Terminix Global$2.05B2.25$125M$0.5371.45

Terminix Global has a net margin of 3.15% compared to R1 RCM's net margin of -1.39%. Terminix Global's return on equity of 4.95% beat R1 RCM's return on equity.

Company Net Margins Return on Equity Return on Assets
R1 RCM-1.39% -1.16% -0.62%
Terminix Global 3.15%4.95%2.67%

61.1% of R1 RCM shares are held by institutional investors. Comparatively, 92.2% of Terminix Global shares are held by institutional investors. 36.8% of R1 RCM shares are held by company insiders. Comparatively, 2.3% of Terminix Global shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

R1 RCM currently has a consensus price target of $16.31, indicating a potential upside of 25.54%. Given R1 RCM's higher probable upside, equities analysts clearly believe R1 RCM is more favorable than Terminix Global.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
R1 RCM
0 Sell rating(s)
5 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.62
Terminix Global
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

R1 RCM has a beta of 0.78, meaning that its stock price is 22% less volatile than the S&P 500. Comparatively, Terminix Global has a beta of 0.78, meaning that its stock price is 22% less volatile than the S&P 500.

In the previous week, R1 RCM had 6 more articles in the media than Terminix Global. MarketBeat recorded 6 mentions for R1 RCM and 0 mentions for Terminix Global. R1 RCM's average media sentiment score of 1.21 beat Terminix Global's score of 0.00 indicating that R1 RCM is being referred to more favorably in the media.

Company Overall Sentiment
R1 RCM Positive
Terminix Global Neutral

R1 RCM received 216 more outperform votes than Terminix Global when rated by MarketBeat users. However, 61.32% of users gave Terminix Global an outperform vote while only 57.94% of users gave R1 RCM an outperform vote.

CompanyUnderperformOutperform
R1 RCMOutperform Votes
281
57.94%
Underperform Votes
204
42.06%
Terminix GlobalOutperform Votes
65
61.32%
Underperform Votes
41
38.68%

Summary

R1 RCM and Terminix Global tied by winning 8 of the 16 factors compared between the two stocks.

Get R1 RCM News Delivered to You Automatically

Sign up to receive the latest news and ratings for RCM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RCM vs. The Competition

MetricR1 RCMManagement services IndustryBusiness SectorNASDAQ Exchange
Market Cap$5.47B$5.37B$6.33B$8.01B
Dividend YieldN/A3.54%2.99%3.99%
P/E Ratio-162.3812.5231.1515.13
Price / Sales2.4346.74821.0369.46
Price / Cash18.6115.5627.7731.24
Price / Book1.949.924.524.60
Net Income$3.30M$225.26M$119.04M$213.66M
7 Day Performance7.05%-1.33%0.41%0.81%
1 Month Performance5.70%-4.05%1.67%3.65%
1 Year Performance-20.45%-10.37%5.93%7.66%

R1 RCM Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TMX
Terminix Global
0 of 5 stars
$37.87
flat
N/AN/A$4.61B$2.05B71.4511,700
MANT
ManTech International
0 of 5 stars
$95.98
flat
N/A+0.0%$3.93B$2.55B32.329,800
PINC
Premier
3.131 of 5 stars
$19.04
+0.3%
$23.50
+23.4%
-27.0%$2.00B$1.34B29.752,800Analyst Forecast
Insider Selling
FC
Franklin Covey
3.7397 of 5 stars
$37.61
+0.4%
$66.33
+76.4%
-1.9%$499.09M$280.52M30.581,160Analyst Forecast
Short Interest ↓
LH
Laboratory Co. of America
4.9058 of 5 stars
$197.32
-1.2%
$243.14
+23.2%
-10.7%$16.63B$12.16B39.7067,000Analyst Upgrade
DGX
Quest Diagnostics
4.9011 of 5 stars
$139.05
-1.6%
$146.17
+5.1%
+3.3%$15.45B$9.25B18.7148,000Analyst Forecast
Positive News
DVA
DaVita
3.0251 of 5 stars
$143.32
+3.5%
$144.67
+0.9%
+55.6%$12.57B$12.14B16.2970,000Positive News
CHE
Chemed
4.8213 of 5 stars
$546.50
-1.6%
$673.50
+23.2%
-0.2%$8.27B$2.26B29.4115,087
CRVL
CorVel
0.3693 of 5 stars
$266.50
-3.7%
N/A+24.7%$4.56B$795.31M60.574,444Analyst Downgrade
Insider Selling
Short Interest ↑
News Coverage
AMED
Amedisys
2.9631 of 5 stars
$96.17
-0.1%
$100.80
+4.8%
+23.7%$3.14B$2.25B-150.2619,000News Coverage
Positive News

Related Companies and Tools

This page (NASDAQ:RCM) was last updated on 5/30/2024 by MarketBeat.com Staff

From Our Partners